pH响应性的虾青素壳聚糖微球制备及应用

以氯乙酸和壳聚糖为原料，通过N,O-羧甲基化化学改性方法制备了水溶性羧甲基壳聚糖，并以此为原料通过乳液法制备羧甲基壳聚糖微球和羧甲基壳聚糖负载虾青素微球。考察了羧甲基壳聚糖微球的形态、分散性和粒径。结果表明，微球最佳制备条件为：羧甲基壳聚糖含量（以水相即去离子水质量为基准，下同）1.0%，油水体积比1∶1，表面活性剂Span 80含量（以油相即液体石蜡体积为基准，下同）4.0%，交联剂戊二醛含量（以油相即液体石蜡体积为基准，下同）7.5%，剪切速率4000 r/min。红外测试表明，微球成功负载虾青素，在虾青素初始添加量为20mg的载药率和包封率分别为10.74%和67.24%。在模拟胃液和模拟肠液中，负载虾青素微球的释放率分别为10%和85%。羧甲基壳聚糖可以用作药物载体。     

环孢素A海藻酸盐缓释微球的制备及体外释放

针对角膜移植术后免疫排斥治疗研究背景,以多肽类免疫抑制剂环孢素A为药物模型,以海藻酸钠为载体材料,以辛癸酸甘油酯和Tween20为添加剂,采用脉冲电场工艺制备药物控释微球载体,对制备工艺参数进行正交设计优化。载药微球最佳制备处方为海藻酸钠质量分数0.8%、油水体积比1∶1.5、Tween20质量分数6.5%、环孢素A投药量65 mg。载药微球球型度优良,平均粒径(36.344±0.103)μm,粒径分布跨距2.314,药物包封率(86.03±0.65)%。在符合漏槽条件的人工泪液中,7 d累积释放率为56.5%,既能满足手术局部对药物浓度需求,又具有良好缓释性能。     

明胶微球载药及其体外释放性能研究

以阿司匹林为药物模型分子,制备了载阿司匹林明胶微球。SEM研究表明,明胶微球在载药后,表面结构变得更为紧实。载药性能探讨表明,当阿司匹林的投药量为16mg时,明胶微球的载药性能较优（载药量为7．3％,包封率为57．5％）。对明胶微球在人工体液中的释药性能研究显示,载阿司匹林明胶微球具有良好的缓释性能。由于具有较大的酸性和胃蛋白酶的存在,微球在人工胃液中药物释放效率较高,在人工胃液和人工肠液中药物的释放率分别为40％和28％,且一级动力学模型对微球的体外药物释放情况拟合度较高。     

水溶性壳聚糖及磁性壳聚糖微球的制备

以废弃蟹壳为原料制备出了高脱乙酰度壳聚糖和脱乙酰度50%的水溶性壳聚糖,通过电位滴定、红外光谱等对产物的脱乙酰度、功能基团作了表征,测定了产物的黏度,结果表明制备的水溶性壳聚糖的动力黏度为82.9 mPa.s。以0.01 mol/L硝酸钴和0.02 mol/L硝酸铁的混合溶液,采用微乳液法制备了纳米铁酸钴,以水溶性壳聚糖为原料制备了壳聚糖/纳米铁酸钴复合微球,TEM结果显示该磁性壳聚糖微球为规则球形,粒径13μm左右,分散性好。     

Preparation and release behavior of carboxymethylated chitosan/alginate microspheres encapsulating bovine serum albumin

Microspheres were prepared from carboxymethylated chitosan (CM‐chitosan) and alginate by emulsion phase separation. Their structure and morphology were characterized with IR spectroscopy and scanning electron microscopy. Bovine serum albumin (BSA) was encapsulated in the microspheres to test the release behavior. The swelling behavior, encapsulation efficiency, and release behavior of BSA from the microspheres at different pHs and with a pH‐gradient condition were investigated. The BSA encapsulation efficiency was calculated to be 80%. The degree of swelling of the microspheres without BSA loaded at pH 7.2 was much higher than that at pH 1.0. The encapsulated BSA was quickly released in a Tris–HCl buffer (pH 7.2), whereas a small amount of BSA was released under acid conditions (pH 1.0) because of the strong electrostatic interaction between ? NH₂ groups of CM‐chitosan and ? COOH groups of alginic acid and a dense structure caused by a Ca²⁺ crosslinked bridge. For the simulation of the processing of the drug under the conditions of the intestine, the microspheres were tested in a pH‐gradient medium, in which an acceleration of the release occurred at pH 7.4 after a lag time at a low pH (5.8–6.8). At pH 7.4, a large amount of BSA was released from the microspheres in a short time because of the rapid swelling of the microspheres. However, the release only depended on the diffusion of BSA at relatively low pHs, this resulted in a relatively low release. © 2004 Wiley Periodicals, Inc. J Appl Polym Sci 92: 878–882, 2004     

Preparation and in vitro release behavior of urapidil hydrochloride loading into microspheres based on poly(L‐lactide)

Microencapsulation of the antihypertensive drug urapidil hydrochloride was investigated as a means of controlling drug release and minimizing or eliminating local side effects. Poly(L ‐lactide) (PLLA) microspheres were prepared using an alternative oil‐in‐water (O/W) solvent‐evaporation method such as the O/W cosolvent solvent‐evaporation method and O/W with various electrolytes added to the aqueous phase method. The surface morphology and the size of the microspheres were observed by scanning electron microscope. Meanwhile, the drug loading efficiency of microspheres and the in vitro release of urapidil hydrochloride from microspheres were performed. The release study indicated that the urapidil hydrochloride‐PLLA microspheres exhibited better sustained release capacity, and the kinetics of urapidil hydrochloride‐PLLA microspheres in vitro release could be described by the Higuchi equation. © 2009 Wiley Periodicals, Inc. J Appl Polym Sci, 2010     

Preparation and release kinetics of carboxymethyl chitosan/cellulose acetate microspheres as drug delivery system

Carboxymethyl chitosan, a water soluble chitosan derivative, was prepared from chitosan using monochloroacetic acid. Carboxymethyl chitosan/cellulose acetate microspheres (CCM) were prepared using the method of W/O/W and emulsification solvent evaporation as drug delivery system. The CCMs prepared were spherical, free‐flowing, and nonaggregated with the smooth appearance and many small pores on the surface. All CCMs prepared had sustained release efficiency for acetaminophen and the optimal formulation was that carboxymethyl chitosan of 2.0% and 1360 KD. In addition, the release rate of drug from CCMs in dilute hydrochloric acid was much slower than that in phosphate buffer saline (pH 6.8) during 24 h. It is illustrated that the drug loaded in CCMs released slower in simulated gastric fluid than that in simulated intestinal fluid. Furthermore, the drug release data showed better fitness with the first order model which indicated that the drug release from CCMs was depended on the drug concentration in the polymeric networks. And the release of drug from CCMs indicated diffusion‐controlled drug release based on Fickian diffusion and accompanied with anomalous transport (i.e., non‐Fickian diffusion) according to the values obtained from Higuchi model and Peppas models. So it was shown that the CCMs might be an ideal sustained release system for acid‐labile drugs both for the solubility of carboxymethyl chitosan and the release media. © 2015 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2015 , 132, 42152.     

改性磁性壳聚糖微球的制备、表征及性能研究

以(NH4)2Fe(SO4)2.6H2O、NH4Fe(SO4)2.12H2O和壳聚糖为原料,经羟丙基化、胺基化,采用一步包埋法制备了一种新型的多胺基化磁性壳聚糖微球。通过正交实验法确定了磁性微球的最佳制备条件,即搅拌速度1200r/min,壳聚糖用量3.0g,环氧氯丙烷用量2.5mL,乙二胺用量2.5mL。并用IR、TG、XRD和SEM对其结构及形貌进行了表征。结果表明,Fe3O4磁性粒子已包埋了一层胺基化壳聚糖。磁性微球胺基含量为2.302mmol/g;呈较规则的球形,平均粒径为209nm,且具有顺磁性和良好的耐酸性。     

羧化改性壳聚糖微球的制备及吸附硝基酚的性能

采用反相悬浮环氧氯丙烷交联、氯乙酸羧甲基化制备交联羧化壳聚糖微球,用红外光谱和扫描电镜对微球进行表征,并用于2,4-二硝基苯酚的吸附研究。考察了吸附时间、溶液pH值、酚的浓度和NaCl等因素对2,4-二硝基苯酚吸附的影响。结果表明,羧化改性交联壳聚糖微球具有较好的耐酸碱性能,对2,4-二硝基苯酚有良好的吸附性能,在pH值为3.6条件下,吸附在瞬间就能达到平衡,吸附量达230 mg.g-1,吸附符合Freundlich等温方程。     

壳聚糖希夫碱及壳聚糖改性微球的吸附性能研究

以壳聚糖和对二甲氨基苯甲醛为原料合成壳聚糖希夫碱,以壳聚糖希夫碱为底物,采用反相悬浮聚合法,制备壳聚糖希夫碱微球。对二者的吸附性能进行比较研究。结果表明,希夫碱微球的吸附性能优于壳聚糖希夫碱,对四氧化三铁的吸附容量分别为113.179 mg/g和39.279 mg/g,对亚甲基蓝的吸附平衡时间均为150 min,饱和吸附容量随着亚甲基蓝初始质量浓度的增大而增大,且微球的吸附容量大于壳聚糖希夫碱,吸附率不随浓度增大单调递增,而是有一极大值。     

pH响应虾青素羧甲基壳聚糖微球的制备与应用

以氯乙酸和壳聚糖为原料,通过N,O-羧甲基化化学改性方法制备了水溶性羧甲基壳聚糖,并以此为原料通过乳液法制备羧甲基壳聚糖微球和羧甲基壳聚糖负载虾青素微球.考察了羧甲基壳聚糖微球的形态、分散性和粒径.结果表明,微球最佳制备条件为:羧甲基壳聚糖含量(以水相即去离子水质量为基准,下同)1.0％,油水体积比1:1,表面活性剂S...     

碘化钾-Cd(Ⅱ)-罗丹明B离子缔合分光光度法测定土壤中微量镉

将0. 5 g土壤进行消解,采用碘化钾-Cd(Ⅱ)-罗丹明B离子缔合分光光度法测定土壤中微量镉,最佳反应条件:加入2 m L浓度1 mol/L H2SO4,20%碘化钾-抗坏血酸溶液3 m L,显色40 min,在波长588 nm处测定离子缔合物吸光度。结果表明,Cd(Ⅱ)浓度在0. 25～2. 0μg/m L范围内符合郎伯-比尔定律。本方法测定结果相对标准偏差小于2%,方法检出限2. 1μg/kg,加标回收率98. 90%～100. 60%。实验表明,校园内土壤镉含量0. 035～0. 050 mg/kg范围内,几乎无金属镉污染。     

磁性壳聚糖微球的制备及其固定化乳糖酶的研究

采用水热法制备得到磁性Fe_3O_4纳米粒子,以壳聚糖、制备的Fe_3O_4为原料,采用乳化交联法成功制备了磁性壳聚糖微球,并通过SEM、FTIR、VSM、XRD对其进行表征。进一步以制备的磁性壳聚糖微球为载体,采用吸附法制备磁性壳聚糖微球固定化乳糖酶。以酶活力为考察指标,研究了不同固定化条件对制备固定化酶的影响,以及固定化酶的酶学性质。结果表明,乳糖酶的最佳固定化条件为:固定化时间4 h,pH为7.0,乳糖酶酶液浓度为0.6 mg/mL,固定化酶相对于游离酶的pH稳定性和温度稳定性均有一定程度的提高,固定化酶重复使用5次后,酶活仍保留65%以上。     

Preparation of chitosan nanocapsules and their release properties

Chitosan nanocapsules are prepared using poly(S-co-MAA) particles as the template and cross-linked chitosan with glutaraldehyde as shell, the core templates are removed by THF. The template particles and nanocapsules are characterized by FESEM and TEM. By dissolution of ibuprofen in the chloroform droplets prepares the poly(S-co-MAA), drug-loaded nanocapsules are also fabricated. It is found that the loaded drug can be released again in a sustained manner for up to 80 h.     

Preparation and characterization of venlafaxine hydrochloride‐loaded chitosan nanoparticles and in vitro release of drug

The venlafaxine hydrochloride (VHL)‐loaded chitosan nanoparticles were prepared by ionic gelation of chitosan (CS) using tripolyphosphate (TPP). The nanoparticles were characterized using FTIR, differential scanning calorimetry, X‐ray diffraction, dynamic light scattering, transmission electron microscopy, and X‐ray photoelectron spectroscopy. The effect of concentration of CS, polyethylene glycol (PEG), VHL and CS/TPP mass ratio on the particle size and zeta potential of nanoparticles was examined. The particle size of CS/TPP nanoparticles and VHL‐loaded CS/TPP nanoparticles was within the range of 200–400 nm with positive surface charge. In the case of VHL‐loaded nanoparticles and PEG‐coated CS/TPP nanoparticles, the particle size increases and surface charge decreases with increasing concentration of VHL and PEG. Both placebo and VHL‐loaded CS/TPP nanoparticles were observed to be spherical in nature. PEG coating on the surface of CS/TPP nanoparticles was confirmed by XPS analysis. Maximum drug entrapment efficiency (70%) was observed at 0.6 mg/mL drug concentration. In vitro drug release study at 37°C ± 0.5°C and pH 7.4 exhibited initial burst release followed by a steady release. © 2009 Wiley Periodicals, Inc. J Appl Polym Sci, 2009     

Cu(Ⅱ)螯合壳聚糖磁性微球的制备、表征及性能研究

以(NH4)2Fe(SO4)2.6H2O、NH4Fe(SO4)2.12H2O和壳聚糖为原料,经羟丙基化、Cu(Ⅱ)螯合,采用一步包埋法制备了一种Cu(Ⅱ)螯合壳聚糖磁性微球。通过正交实验法确定了磁性微球的最佳制备条件,即搅拌速度1 200 r/min,壳聚糖用量3.0 g,环氧氯丙烷用量1.0 mL,CuCl2.2H2O为0.010 mol。并用IR、TG、XRD和SEM对其结构及形貌进行了表征,结果表明,Fe3O4磁性粒子已包埋了一层Cu(Ⅱ)螯合壳聚糖,呈较规则的球形,平均粒径为240 nm,且具有顺磁性。     

Preparation,characterization, and salicylic acid release behavior of chitosan/poly(vinyl alcohol) blend microspheres

Blend microspheres of chitosan (CS) with poly(vinyl alcohol) (PVA) were prepared as candidates for oral delivery system. CS/PVA microspheres containing salicylic acid (SA), as a model drug, were obtained using the coacervation‐phase separation method, induced by addition of a nonsolvent (sodium hydroxide solution) and then crosslinked with glutaraldehyde (GA) as a crosslinking agent. The microspheres were characterized by Fourier transform infrared spectroscopy, differential scanning calorimetry (DSC), and scanning electron microscopy. Percentage entrapment efficiency, particle size, and equilibrium swelling degree of the microsphere formulations were determined. The results indicated that these parameters were changed by preparation conditions of the microspheres. Effects of variables such as CS/PVA ratio, pH, crosslinker concentration, and drug/polymer (d/p) ratio on the release of SA were studied at three different pH values (1.2, 6.8, and 7.4) at 37°C. It was observed that SA release from the microspheres increased with decreasing CS/PVA ratio and d/p ratio whereas it decreased with the increase in the extent of crosslinking. It may also be noted that drug release was much higher at pH 1.2 than that of at pH 6.8 and 7.4. The highest SA release percentage was obtained as 100% for the microspheres prepared with PVA/CS ratio of 1/2, d/p ratio of 1/2, exposure time to GA of 5 min, and concentration of GA 1.5% at the end of 6 h. © 2008 Wiley Periodicals, Inc. J Appl Polym Sci, 2009     

单分散性PLGA磁性微球制备及其缓释性研究

为获得单分散性PLGA磁性微球,文中以纳米四氧化三铁明胶分散液作为内水相(W1),PLGA（聚乳酸羟基乙酸共聚物）的二氯甲烷溶液作为油相(O),PVA（聚乙烯醇）水溶液作为外水相(W2),利用T型微通道并采用复合乳液法制备PLGA磁性微球,考察流速比和油相与内水相体积比对微球制备的影响。借助FTIR、SEM及VSM（振动样品磁强计）对磁性微球组分、形貌、粒径分布和磁学性能进行表征;并以阿司匹林作为药物模型进行缓释性测试。结果表明：流速比v(W2):v(W1/O)=120:1且体积比V(O):V(W1)=2:1时可均匀成球,其粒径分布系数CV值仅为4.66%,表现出良好单分散性;此时比饱和磁化强度可达1.52emu/g,兼具优异顺磁性。制得的载药微球在60h内表现出阶段性匀速释放,且有较好磁响应性,有望用于磁响应性药物载体。     

Preparation,characterization and in vitro drug release properties of polytrimethylene carbonate/polyadipic anhydride blend microspheres

Polyadipic anhydride (PAA), an aliphatic polyanhydride, and polytrimethylene carbonate (PTMC), an aliphatic polycarbonate, were synthesized via ring opening polymerization of oxepan‐2,7‐dione and melt‐condensation of trimethylene carbonate (1,3 dioxan‐2‐one), respectively. PTMC–PAA blend microspheres containing different ratios of buprenorphine HCl (2, 5, and 10%) were prepared by an oil‐in‐oil emulsion solvent removal method. Microspheres with different ratios of PTMC–PAA (85/15, 70/30, and 55/45) containing 5% buprenorphine HCl were prepared. Microspheres were spherical with visible cracks and pores on the surface. The average particle size of microspheres was around 200 μm for all microspheres. Drug loading efficiency of PTMC–PAA microspheres (85/15, 70/30, and 55/45) was 97.2, 95.2, and 70.2%, respectively. With the increase in the PTMC ratio, the melting point and the enthalpy of melting were both decreased. The mechanism for drug release from PTMC–PAA blend microspheres were generally a combination of drug diffusion through polymers and biodegradation of the polymers. In first three days, the release from microspheres followed zero order kinetics and was dependent on the PAA content. After three days the drug release from microspheres followed first order kinetics. In conclusion it was demonstrated that buprenorphine HCl release from microspheres could be successfully controlled by using different ratios of PTMC–PAA blends. © 2006 Wiley Periodicals, Inc. J Appl Polym Sci 101: 2377–2383, 2006     

Preparation of injectable paclitaxel sustained release microspheres by spray drying for inhibition of glioma in vitro

The major aim of this work was to prepare injectable paclitaxel‐loaded poly(D ,L ‐lactide) microspheres for the inhibition of brain glioma. Paclitaxel‐loaded PLA microspheres were prepared by spray drying method employing ethyl acetate as solvent. And the microspheres were characterized by scanning electron microscopy (SEM) for the morphology and differential scanning calorimetry for thermal analysis. The encapsulation efficiency (EE) and in vitro release profiles of paclitaxel‐loaded microspheres were determined by using ultraviolet spectrophotometer. The results showed that the microspheres possess a narrow size distribution with the average diameter of 4.6 μm. The surface of the microspheres was smooth, and the paclitaxel dispersed in microspheres in amorphous state. The solvent residue was 0.03%, and the EE reaches ～ 90%. The microspheres exhibited a sustained release behavior, and the release period last for at least three months, depending on the EE of the microspheres. The γ irradiation sterilization had little effect on the EE and drug release in vitro. Compared with the commercial formulation, the sustained release microsphere showed a stronger inhibition on the tumor cells, suggesting the potential application of long‐term delivery of paclitaxel‐loaded PLA microspheres in clinic tumor therapy. © 2009 Wiley Periodicals, Inc. J Appl Polym Sci, 2010